ReviewMolecular cancer2018
The rationale for druggability of CCDC6-tyrosine kinase fusions in lung cancer.
Aniello Cerrato et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it
ReviewMolecular cancer2018
Aniello Cerrato et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.